ASCO: Bladder Sparing Studied in Muscle-Invasive Bladder Cancer
Transurethral resection then gemcitabine, cisplatin, plus nivolumab with intact bladder in selected patients studied in phase 2 trial
Transurethral resection then gemcitabine, cisplatin, plus nivolumab with intact bladder in selected patients studied in phase 2 trial
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.